236 related articles for article (PubMed ID: 19801324)
1. Special report: Consensus conference III. Image-detected breast cancer: state-of-the-art diagnosis and treatment.
Silverstein MJ; Recht A; Lagios MD; Bleiweiss IJ; Blumencranz PW; Gizienski T; Harms SE; Harness J; Jackman RJ; Klimberg VS; Kuske R; Levine GM; Linver MN; Rafferty EA; Rugo H; Schilling K; Tripathy D; Vicini FA; Whitworth PW; Willey SC
J Am Coll Surg; 2009 Oct; 209(4):504-20. PubMed ID: 19801324
[No Abstract] [Full Text] [Related]
2. Image-detected breast cancer: state of the art diagnosis and treatment.
Silverstein MJ; Lagios MD; Recht A; Allred DC; Harms SE; Holland R; Holmes DR; Hughes LL; Jackman RJ; Julian TB; Kuerer HM; Mabry HC; McCready DR; McMasters KM; Page DL; Parker SH; Pass HA; Pegram M; Rubin E; Stavros AT; Tripathy D; Vicini F; Whitworth PW
J Am Coll Surg; 2005 Oct; 201(4):586-97. PubMed ID: 16183499
[No Abstract] [Full Text] [Related]
3. International consensus conference. Image-detected breast cancer: state of the art diagnosis and treatment.
International Breast Cancer Consensus Conference
Breast J; 2002; 8(2):70-6. PubMed ID: 11896750
[No Abstract] [Full Text] [Related]
4. Breast cancer diagnosed during pregnancy and lactation: biological features and treatment options.
Gentilini O; Masullo M; Rotmensz N; Peccatori F; Mazzarol G; Smeets A; Simsek S; De Dosso S; Veronesi P; Intra M; Zurrida S; Viale G; Goldhirsch A; Veronesi U
Eur J Surg Oncol; 2005 Apr; 31(3):232-6. PubMed ID: 15780556
[TBL] [Abstract][Full Text] [Related]
5. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
6. Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
Li BD; Sicard MA; Ampil F; Abreo F; Lilien D; Chu QD; Burton GV
Oncology; 2010; 79(1-2):3-12. PubMed ID: 21051912
[TBL] [Abstract][Full Text] [Related]
7. Premalignant lesions: diagnosis, evaluation, and management.
Tejada-Berges T
Clin Obstet Gynecol; 2011 Mar; 54(1):133-40. PubMed ID: 21278512
[TBL] [Abstract][Full Text] [Related]
8. [Diagnosis and treatment of occult breast cancer: report of 23 cases].
Zhong Y; Sun Q; Huang HY; Zhou YD; Guan JH; Mao F; Lin Y; Xu YL
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):716-8. PubMed ID: 21122392
[TBL] [Abstract][Full Text] [Related]
9. Case records of the Massachusetts General Hospital. Case 25-2009. A 36-year-old woman with hormone-receptor-positive breast cancer.
Burstein HJ; Souter I; D'Alessandro HA; Sgroi DC
N Engl J Med; 2009 Aug; 361(7):699-707. PubMed ID: 19675333
[No Abstract] [Full Text] [Related]
10. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
11. Occult breast lesion localization plus sentinel node biopsy (SNOLL): experience with 959 patients at the European Institute of Oncology.
Monti S; Galimberti V; Trifiro G; De Cicco C; Peradze N; Brenelli F; Fernandez-Rodriguez J; Rotmensz N; Latronico A; Berrettini A; Mauri M; Machado L; Luini A; Paganelli G
Ann Surg Oncol; 2007 Oct; 14(10):2928-31. PubMed ID: 17674108
[TBL] [Abstract][Full Text] [Related]
12. Integrative tumor board: recurrent breast cancer or new primary? Radiation oncology.
Hirsch A
Integr Cancer Ther; 2003 Sep; 2(3):272-6. PubMed ID: 15035891
[No Abstract] [Full Text] [Related]
13. Ductal carcinoma in situ of the breast: our experience.
Ruggiero R; Procaccini E; Sanguinetti A; Cremone C; Gili S; Docimo G; Docimo L; Sparavigna L; Gubitosi A; Parmeggiani D; Avenia N
G Chir; 2009 Mar; 30(3):121-4. PubMed ID: 19351465
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer in very young women.
Liukkonen S; Leidenius M; Saarto T; Sjöström-Mattson J
Eur J Surg Oncol; 2011 Dec; 37(12):1030-7. PubMed ID: 21937191
[TBL] [Abstract][Full Text] [Related]
15. [The consensus conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999].
Schwartz GF; Solin LJ; Olivotto IA; Ernster VL;
Bull Cancer; 2000 Jun; 87(6):499-506. PubMed ID: 10903791
[No Abstract] [Full Text] [Related]
16. Ductal carcinoma in situ.
Bleicher RJ
Surg Clin North Am; 2013 Apr; 93(2):393-410. PubMed ID: 23464692
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
[TBL] [Abstract][Full Text] [Related]
18. [Breast-conserving therapy in breast cancer].
Marcollet A; Doridot V; Nos C
Rev Prat; 2004 Apr; 54(8):847-53. PubMed ID: 15274458
[TBL] [Abstract][Full Text] [Related]
19. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: implications for diagnosis, surgical and medical treatment.
Biglia N; Mariani L; Sgro L; Mininanni P; Moggio G; Sismondi P
Endocr Relat Cancer; 2007 Sep; 14(3):549-67. PubMed ID: 17914088
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up results of breast cancer patients with sentinel lymph node biopsy using periareolar injection.
Imasato M; Shimazu K; Tamaki Y; Taguchi T; Tanji Y; Kim SJ; Noguchi S
Am J Surg; 2010 Apr; 199(4):442-6. PubMed ID: 19596117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
